APPLICATION
ANDA071821
TYPE
ANDA
ORIGINAL APPROVAL
1988-04-08
LATEST ACTION
1995-12-07
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
METHYLDOPA AND HYDROCHLOROTHIAZIDEDiscontinued
HYDROCHLOROTHIAZIDE 30MG, METHYLDOPA 500MG · TABLET · ORAL
Approval history
1995-12-07Labeling · Supplement 9AP
1991-09-16Labeling · Supplement 7AP
1991-03-25Labeling · Supplement 6AP
1990-03-16Labeling · Supplement 2AP
1988-04-08OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.